This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on december 3, 2021.Upon further investigation of the reported event, the following information is new and/or changed: g6 (indication that this is a follow-up report).H2 (follow-up due to additional information and device evaluation).H4 (device manufacture date).H6 (identification of evaluation codes 10, 3331, 213, 4315).Type of investigation: #1: 10 - testing of actual/suspected device.Type of investigation #2: 3331 - analysis of production records.Investigation findings: 213 - no device problem found.Investigation conclusions: 4315 - cause not established.The affected sample was inspected upon receipt with no visual anomalies.The sample was setup onto two lab owned stockart drives and the sample attached appropriately to the drive motors.Critical dimensions related to the interface between the adapter and the drive motor were checked.All checked dimensions were within specification.As the event could not be replicated and the adapter measured within specification, it is not possible to determine a root cause to this event.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|